
TY  - JOUR
TI  - EPIDEMIOLOGY OF RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_10.x
DO  - doi:10.1111/j.1479-8077.2006.00199_10.x
SP  - A54
EP  - A66
PY  - 2006
ER  - 

TY  - JOUR
TI  - SCLERODERMA AND RELATED SYNDROMES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_26.x
DO  - doi:10.1111/j.1479-8077.2006.00199_26.x
SP  - A225
EP  - A230
PY  - 2006
ER  - 

TY  - JOUR
TI  - DIAGNOSTICS AND IMAGING PROCEDURES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_8.x
DO  - doi:10.1111/j.1479-8077.2006.00199_8.x
SP  - A45
EP  - A51
PY  - 2006
ER  - 

TY  - JOUR
TI  - EDUCATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_9.x
DO  - doi:10.1111/j.1479-8077.2006.00199_9.x
SP  - A52
EP  - A54
PY  - 2006
ER  - 

TY  - JOUR
AU  - Thomson, S. J.
AU  - Moran, C.
AU  - Cowan, M. L.
AU  - Musa, S.
AU  - Beale, R.
AU  - Treacher, D.
AU  - Hamilton, M.
AU  - Grounds, R. M.
AU  - Rahman, T. M.
TI  - Outcomes of critically ill patients with cirrhosis admitted to intensive care: an important perspective from the non-transplant setting
JO  - Alimentary Pharmacology & Therapeutics
VL  - 32
IS  - 2
SN  - 0269-2813
UR  - https://doi.org/10.1111/j.1365-2036.2010.04341.x
DO  - doi:10.1111/j.1365-2036.2010.04341.x
SP  - 233
EP  - 243
PY  - 2010
AB  - Aliment Pharmacol Ther 2010; 32: 233?243 Summary Background? Hospital admissions for cirrhosis have been increasing in the United Kingdom, leading to increased pressure on intensive care (ICU) services. Outcome data for patients admitted to ICU are currently limited to transplant centre reports, with mortality rates exceeding 70%. These tertiary reports could fuel a negative bias when patients with cirrhosis are reviewed for ICU admission in secondary care. Aims? To determine whether disease severity and mortality rates in non-transplant general ICU are less severe than those reported by tertiary datasets. Methods? A prospective dual-centre non-transplant ICU study. Admissions were screened for cirrhosis and physiological and biochemical data were collected. Disease-specific and critical illness scoring systems were evaluated. Results? Cirrhosis was present in 137/4198 (3.3%) of ICU admissions. ICU and hospital mortality were 38% and 47%, respectively; median age 50 [43?59] years, 68% men, 72% alcoholic cirrhosis, median Child Pugh Score (CPS) 10 [8?11], Model for End-Stage Liver Disease (MELD) 18 [12?24], Acute Physiology and Chronic Health Evaluation II score (APACHE II) 16 [13?22]. Conclusions? Mortality rates and disease staging were notably lower than in the published literature, suggesting that patients have a more favourable outlook than previously considered. Transplant centre data should therefore be interpreted with caution when evaluating the merits of intensive care admission for patients in general secondary care ICUs.
ER  - 

TY  - JOUR
TI  - 17th International Congress of Immunology, 19–23 October 2019, Beijing, China
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S3
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201970400
DO  - doi:10.1002/eji.201970400
SP  - 1
EP  - 2223
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Anaesthesiologica Scandinavica
JA  - Acta Anaesthesiol. Scand.
VL  - 59
IS  - S121
SN  - 0001-5172
UR  - https://doi.org/10.1111/aas.12556
DO  - doi:10.1111/aas.12556
SP  - 1
EP  - 60
PY  - 2015
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00419.x
DO  - doi:10.1111/j.1440-1797.2005.00419.x
SP  - A1
EP  - A116
PY  - 2005
ER  - 

TY  - JOUR
TI  - MYOPATHIES AND SOFT TISSUE RHEUMATISM INCLUDING FIBROMYALGIA
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_17.x
DO  - doi:10.1111/j.1479-8077.2006.00199_17.x
SP  - A99
EP  - A101
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODEL
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_25.x
DO  - doi:10.1111/j.1479-8077.2006.00199_25.x
SP  - A211
EP  - A225
PY  - 2006
ER  - 

TY  - JOUR
TI  - SYSTEMIC LUPUS ERYTHEMATOSUS – AETIOLOGY AND PATHOGENESIS/ANIMAL MODELS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_29.x
DO  - doi:10.1111/j.1479-8077.2006.00199_29.x
SP  - A247
EP  - A253
PY  - 2006
ER  - 

TY  - JOUR
TI  - CARTILAGE IN BONE BIOLOGY AND PATHOPHYSIOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_5.x
DO  - doi:10.1111/j.1479-8077.2006.00199_5.x
SP  - A33
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
AU  - Mohite, Prashant N.
AU  - Sabashnikov, Anton
AU  - Raj, Binu
AU  - Hards, Rachel
AU  - Edwards, Gemma
AU  - García-Sáez, Diana
AU  - Zych, Bartlomiej
AU  - Husain, Mubassher
AU  - Jothidasan, Anand
AU  - Fatullayev, Javid
AU  - Zeriouh, Mohamed
AU  - Weymann, Alexander
AU  - Popov, Aron-Frederik
AU  - De Robertis, Fabio
AU  - Simon, André R.
TI  - Minimally Invasive Left Ventricular Assist Device Implantation: A Comparative Study
JO  - Artificial Organs
JA  - Artif Organs
VL  - 42
IS  - 12
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.13269
DO  - doi:10.1111/aor.13269
SP  - 1125
EP  - 1131
KW  - Long-term ventricular assist
KW  - Minimally invasive
KW  - Sternal sparing
KW  - Thoracotomy
KW  - Mechanical circulatory assist
KW  - Survival
PY  - 2018
AB  - Abstract Left ventricular assist device (LVAD) is now a routine therapy for advanced heart failure. Minimally invasive approach via thoracotomy for LVAD implantation is getting popular due to its potential advantage over the conventional sternotomy approach in terms of reduced risk at re-operation due to sternal sparing. We compared the approaches (thoracotomy and sternotomy) to determine the superiority. Minimally invasive approach involved fitting of the LVAD inflow cannula into left ventricle apex via left anterior thoracotomy and anastomosis of outflow graft to ascending aorta via right anterior thoracotomy. In the sternotomy approach, both the procedures were performed via sternotomy. Outcomes in patients after LVAD implantation were compared depending on these approaches for the surgery. Two hundred and five continuous flow LVAD implantations performed between July 2006 and June 2015 at a single center were divided based on surgical approach, that is, sternotomy (n?=?180) and thoracotomy (n?=?25) groups. There was no significant difference between the groups in relation to patient demographics, preoperative hemodynamic parameters, laboratory markers, or risk factors. There was no significant difference between the groups in terms of postoperative hemodynamic parameters, laboratory markers, bleeding and requirement of blood products, intensive care unit, and hospital stay or complications of LVAD surgery. There were no significant differences in terms of long-term survival (Log-Rank P?=?0.953), however, thoracotomy, compared to sternotomy approach, incurred significantly less requirement of temporary right ventricular assist (4 vs. 19.4%, P?=?0.041). Minimally invasive bilateral thoracotomy approach for LVAD implantation in addition to benefits of sternal sparing avoids dilatation of right ventricle and reduces chances of right ventricular failure requiring temporary right ventricular assist.
ER  - 

C7  - pp. 179-184
TI  - Fever
SN  - 9780632064175
UR  - https://doi.org/10.1002/9780470757253.ch18
DO  - doi:10.1002/9780470757253.ch18
SP  - 179-184
KW  - fever
KW  - pyrexia of unknown origin (PUO)
KW  - rash
KW  - lymphadenopathy
KW  - eosinophilia
PY  - 2018
AB  - Summary This chapter contains sections titled: Prolonged pyrexia of unknown origin (PUO) Fever and rash Fever and lymphadenopathy Eosinophilia
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4–7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 9780632064175
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
AU  - Drabik, Anna
AU  - Bierczynska-Krzysik, Anna
AU  - Bodzon-Kulakowska, Anna
AU  - Suder, Piotr
AU  - Kotlinska, Jolanta
AU  - Silberring, Jerzy
TI  - Proteomics in neurosciences
JO  - Mass Spectrometry Reviews
JA  - Mass Spectrom. Rev.
VL  - 26
IS  - 3
SN  - 9780632064175
UR  - https://doi.org/10.1002/mas.20131
DO  - doi:10.1002/mas.20131
SP  - 432
EP  - 450
KW  - neurodegenerative disorders
KW  - cancer
KW  - addiction
KW  - sample preparation
KW  - proteomic
KW  - techniques
PY  - 2007
AB  - Abstract This review provides an outline of the most important proteomic applications in the study of neurodegenerative disorders including Alzheimer's (AD), Parkinson's (PD), Huntington's (HD), and prion diseases, and also discusses advances in cancer and addiction. One of the scopes is to illustrate the potential of proteomics in the biomarkers discovery of these diseases. Finally, this article comments the advantages and drawbacks of the most commonly used techniques and methods for samples preparation. ? 2007 Wiley Periodicals, Inc., Mass Spec Rev
ER  - 

TY  - JOUR
TI  - CELL RECEPTOR-LIGAND INTERACTION, SIGNALING AND ACTIVATION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780632064175
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_6.x
DO  - doi:10.1111/j.1479-8077.2006.00199_6.x
SP  - A39
EP  - A39
PY  - 2006
ER  - 

TY  - JOUR
TI  - CYTOKINES AND INFLAMMATORY MEDIATORS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9780632064175
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_7.x
DO  - doi:10.1111/j.1479-8077.2006.00199_7.x
SP  - A39
EP  - A45
PY  - 2006
ER  - 

TY  - JOUR
TI  - Main Symposia And Workshops
JO  - The FEBS Journal
JA  - FEBS J
VL  - 280
IS  - s1
SN  - 9780632064175
UR  - https://doi.org/10.1111/febs.12340
DO  - doi:10.1111/febs.12340
SP  - 3
EP  - 617
PY  - 2013
ER  - 

TY  - JOUR
AU  - WESSELDIJK, F.
AU  - FEKKES, D.
AU  - HUYGEN, F. J. P. M.
AU  - VAN DE HEIDE-MULDER, M.
AU  - ZIJLSTRA, F. J.
TI  - Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1
JO  - Acta Anaesthesiologica Scandinavica
VL  - 52
IS  - 5
SN  - 9780632064175
UR  - https://doi.org/10.1111/j.1399-6576.2008.01638.x
DO  - doi:10.1111/j.1399-6576.2008.01638.x
SP  - 688
EP  - 694
KW  - Complex regional pain syndrome type 1
KW  - glutamate
KW  - glutamine
KW  - arginine
KW  - VAS
KW  - pain
PY  - 2008
AB  - Background: Various inflammatory mediators have been identified as potential contributors to complex regional pain syndrome type 1 (CRPS1), but these mediators do not entirely explain certain manifestations of the syndrome, such as pain. The objective of this study was to investigate the role of amino acids in the pathogenesis of CRPS1. Methods: We used HPLC to determine plasma concentrations of 16 amino acids, especially those related to the NMDA receptor (e.g., glutamate and glycine) and nitric oxide (NO) synthesis (e.g., arginine and citrulline) in patients with CRPS1 (n=64) and age- and sex-matched healthy controls (n=51). Patients rated pain intensity (visual analog scale) and the subjective experience of pain intensity (McGill Pain Questionnaire). Psychological dysfunction was assessed using the SCL-90. Results: Relative to controls, in CRPS1 patients, plasma levels of glutamate, arginine, taurine, and glycine were increased, and plasma levels of glutamine and the ratio of citrulline to arginine were decreased. Remarkably, in CRPS1 patients there was a highly significant inverse correlation between glutamine and glutamate, although the sum of molar concentrations of glutamate and glutamine remains unchanged. Subjective measures of pain and indicators of psychoneuroticism and emotional instability did not correlate with amino acid levels. Conclusion: This study shows for the first time a pronounced increase in amino acid levels in this chronic pain syndrome. The marked differences in glutamate, glutamine, glycine, taurine and arginine levels between patients and controls suggest the involvement of both the NDMA receptor and the endothelium-dependent arginine-NO system in CRPS1.
ER  - 
